Oncology Institute (TOIIW) Interest Expenses (2021 - 2026)

Oncology Institute has reported Interest Expenses for 6 years, with the latest figure at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses fell 65.28% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $7.6 million (down 31.05% YoY), and the FY2025 full-year result was $11.3 million, up 50.43% from the prior year.
• Interest Expenses for Q1 2026 stood at $1.9 million, up from $1.9 million in the prior quarter.
• The five-year high for Interest Expenses was $5.6 million in Q1 2025, with the low at $61000.0 in Q2 2022.
• Historically, Interest Expenses has averaged $1.9 million across 5 years, with a median of $1.9 million in 2025.
• Annual changes were most pronounced in 2023 — Interest Expenses surged 2585.25% — and 2026, when it tumbled 65.28%.
• Oncology Institute's Interest Expenses stood at $61000.0 in 2022, then surged by 3081.97% to $1.9 million in 2023, then tumbled by 39.82% to $1.2 million in 2024, then surged by 64.04% to $1.9 million in 2025, then advanced by 0.94% to $1.9 million in 2026.
• The last three Interest Expenses figures came in at $1.9 million (Q1 2026), $1.9 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.